Alcohol use disorder
also known as AUD, alcoholism, alcohol dependence
Medically reviewed by the Shrinkopedia editorial team, led by Shariq Refai, MD, MBA, FAPA.
18 min read · 3,940 words
- Medically reviewed . Reviewed by a board-certified psychiatrist before publication.
- Sourced from primary literature . DSM-5-TR, NICE, the American Psychiatric Association, the NIMH, Cochrane, peer-reviewed research.
- Dated and kept current . Every entry shows when it was published, reviewed, and last updated.
- Honest about uncertainty . Each entry carries an evidence-strength rating and a "what we know and what we don't" section.
- Independent . No advertising, no affiliate revenue, no sponsored content.
Alcohol use disorder is a specific medical diagnosis with clear criteria, not a matter of willpower or moral failing. It's defined by a pattern of alcohol use that causes clinically significant impairment or distress, with at least 2 of 11 features present within a 12-month period. It's common: lifetime prevalence in the United States is about 29 percent by NESARC-III methodology, with 12-month prevalence around 14 percent. It's often undiagnosed. And it's one of the most treatable psychiatric conditions when the person engages. Evidence-based treatment combines medication (naltrexone, acamprosate, disulfiram, and increasingly topiramate or gabapentin) with psychosocial support and mutual-help involvement when useful. Outcomes are substantially better than the pessimism that surrounds the condition suggests. Reduced-drinking goals are viable for many patients with mild to moderate AUD; abstinence is safer for severe AUD or when significant liver disease is present.
Prefer the quick definition? Read this term on Shrinktionary →
Questions people ask
Do I have to hit rock bottom to get help?
No. The idea that people must hit rock bottom before treatment can work isn't supported by evidence. Earlier treatment engagement typically produces better outcomes. Milder AUD often responds well to brief interventions in primary care or a single course of therapy. Waiting for the situation to become catastrophic before intervening is not clinically advised.
Is alcohol use disorder curable?
Recovery is real and common. Population studies find a substantial proportion of people who ever met criteria for AUD are in sustained remission at any given time. The underlying vulnerability often persists, which is why maintenance approaches (medication, therapy, mutual-help groups) matter over the long term. Some people achieve stable abstinence or reduced drinking that lasts decades.
Are AA and other 12-step programs effective?
They help many people. Recent meta-analyses (Kelly et al. Cochrane 2020) find AA and 12-step-facilitated therapy comparable to or better than other treatments for maintaining abstinence in some studies. They aren't the only path, and they aren't a fit for everyone. SMART Recovery, Refuge Recovery, Women for Sobriety, and other alternatives are also legitimate options.
Do I need medication?
For alcohol use disorder specifically, medications like naltrexone, acamprosate, and disulfiram have strong evidence and are often underused. Combining medication with therapy typically outperforms therapy alone. Medication doesn't mean giving up; it means using tools that work.
Can I drink normally after treatment?
For some people with mild alcohol use disorder, yes, particularly with therapy and monitoring. For most people with moderate or severe alcohol use disorder, abstinence is more sustainable than trying to return to controlled drinking. The choice belongs with the person and their clinician, and can be revisited over time.
Is inpatient rehab necessary?
Not for most patients. Outpatient treatment, IOP, or PHP are appropriate for many patients and produce comparable outcomes to residential treatment for many. Residential treatment is more useful for severe AUD with unstable home environment, severe co-occurring conditions, or history of failed outpatient attempts.
How long does treatment take?
Acute treatment for withdrawal is days. Initial stabilization is weeks. Medication-based treatment often continues for months to years. Behavioral therapies typically run 12 to 20 sessions in acute phase, with less intensive follow-up over years. Recovery is often thought of as a lifelong process rather than a discrete treatment episode, though this framing isn't universal.
What should I say if I don't want to drink at a social event?
"I'm not drinking tonight" is a complete sentence. Most people don't push. If someone does, they're often more interested in their own drinking than in yours. Ordering a nonalcoholic drink (sparkling water, mocktail, N/A beer) reduces the visible difference.
Does one drink of alcohol reset treatment?
Not necessarily. Return to drinking is common in early recovery. A single drinking episode is not evidence that treatment failed. What matters is what happens next: getting back to treatment, understanding what happened, adjusting the plan. Extended shame after a slip often makes another slip more likely.
Can medications for AUD be used long-term?
Yes. Naltrexone, acamprosate, and other medications can be continued as long as they're helping. There's no requirement to taper off after a set time, and continuing medications is often protective against relapse.
What if my drinking is only on weekends?
That can still meet criteria for AUD. The DSM-5-TR criteria don't require daily drinking. If weekend drinking meets 2 or more criteria (loss of control, tolerance, continued use despite problems, etc.), the diagnosis applies. Severity is determined by the number of features, not by drinking pattern alone.
Is alcohol worse than other drugs?
By public health metrics (mortality, morbidity, social harm), alcohol produces more total harm than most other substances, largely because it's legal and widely used. Individual drugs have specific risks alcohol lacks (overdose risk for opioids, for example), but at the population level, alcohol is among the most harmful substances.
What alcohol use disorder is
Under DSM-5-TR, alcohol use disorder is diagnosed when at least 2 of the following 11 features occur within a 12-month period, causing clinically significant impairment or distress:
1. Alcohol taken in larger amounts or over longer periods than intended 2. Persistent desire or unsuccessful efforts to cut down or control use 3. A great deal of time spent obtaining, using, or recovering from alcohol 4. Craving or a strong desire to use alcohol 5. Recurrent use resulting in failure to fulfill major role obligations at work, school, or home 6. Continued use despite persistent social or interpersonal problems caused or worsened by alcohol 7. Giving up important social, occupational, or recreational activities because of alcohol 8. Recurrent use in physically hazardous situations 9. Continued use despite knowledge of a physical or psychological problem caused or worsened by alcohol 10. Tolerance (needing more to get the same effect, or reduced effect with the same amount) 11. Withdrawal symptoms, or use to relieve or avoid withdrawal
Severity is graded: mild (2-3 features), moderate (4-5), severe (6 or more).
The prior DSM-IV distinction between alcohol abuse and alcohol dependence was collapsed into this single graded diagnosis in DSM-5. The older terms are still used clinically but the DSM-5-TR framework is the current standard. The ICD-11 uses parallel criteria under "harmful pattern of use of alcohol" and "alcohol dependence."
What it looks like across the range
Most people with alcohol use disorder are not the stereotype. Many maintain employment, families, and outward stability while meeting criteria. Common presentations:
- Steady daily drinking well above low-risk limits, with tolerance and difficulty stopping
- Weekend or evening binge drinking with regular loss of control
- Drinking to manage anxiety, sleep problems, PTSD symptoms, or depression
- Drinking that gradually escalates over years without a clear turning point
- Episodic drinking with sustained periods of not drinking followed by relapses
- Drinking that is mostly hidden from family or friends
- Drinking that seems socially normal within a peer group but exceeds low-risk drinking guidelines by a substantial margin
The condition doesn't require daily drinking, doesn't require intoxication at work, and doesn't require obvious functional decline. The DSM-5-TR criteria define the disorder by pattern rather than by any single behavior. This is one reason people often don't recognize their own AUD: the outward markers of stereotypical alcoholism may be absent for years while the underlying pattern meets clinical criteria.
Low-risk drinking guidelines from NIAAA (United States) are no more than 4 drinks on any single day and no more than 14 drinks per week for men, and no more than 3 drinks on any single day and no more than 7 drinks per week for women. Drinking above these levels doesn't automatically mean AUD, but it substantially increases risk of developing AUD and of alcohol-related medical problems. Some professional bodies internationally have moved to more conservative recommendations, particularly around cancer risk.
Withdrawal
Alcohol withdrawal is medically important. Depending on the intensity and duration of drinking, withdrawal can range from mild (tremor, anxiety, sleep disruption, mild autonomic activation) to severe (seizures, delirium tremens). Delirium tremens (severe autonomic instability, confusion, hallucinations, fever) has real mortality risk (historically 5 to 15 percent, now around 1 to 5 percent with modern treatment).
Timeline:
- 6 to 12 hours after last drink: mild symptoms (tremor, anxiety, nausea, insomnia)
- 12 to 24 hours: worsening symptoms, alcoholic hallucinosis in some patients
- 24 to 48 hours: peak risk of withdrawal seizures
- 48 to 96 hours: peak risk of delirium tremens
Anyone with heavy sustained drinking who is planning to stop should discuss with a medical clinician, not attempt cold-turkey stoppage on their own. Medical detoxification (often outpatient, sometimes inpatient) is available and reduces the risks substantially. Benzodiazepines are the first-line treatment for withdrawal; specific choice and dosing depend on the clinical picture. Symptom-triggered dosing using scales like the CIWA-Ar is standard in medical settings.
Post-acute withdrawal (persistent sleep disturbance, mood changes, anxiety) can last weeks to months after acute withdrawal resolves. Understanding this pattern helps patients tolerate the extended recovery period without concluding treatment isn't working.
Screening
The AUDIT (Alcohol Use Disorders Identification Test), developed by the WHO, is the most widely validated screening instrument, with 10 items covering quantity, frequency, and problems. The AUDIT-C is a 3-item short version covering quantity and frequency, widely used in primary care. A score of 8 or more on the full AUDIT (or 4+ for men, 3+ for women on AUDIT-C) suggests hazardous drinking warranting further assessment.
The CAGE questionnaire (4 questions) is a shorter but less sensitive screening tool.
Single-item screening ("How many times in the past year have you had 5 or more drinks in a day for men, or 4 or more for women?") has been validated in primary care and takes less than a minute.
Biological markers (elevated GGT, MCV, CDT) are useful for tracking recent heavy drinking but are not sensitive or specific enough for diagnosis. They are more useful for monitoring than for screening.
Differential diagnosis
Several conditions can produce presentations that overlap with AUD.
Bipolar disorder during hypomanic or manic phases can produce disinhibited drinking that resolves when the mood episode ends. Careful longitudinal history distinguishes bipolar-related drinking from primary AUD, though both often co-occur.
Depression with self-medicating alcohol use produces a different treatment picture than primary AUD. Both usually need treatment.
PTSD with alcohol as self-medication is common enough that AUD assessment routinely includes trauma history.
Anxiety disorders with alcohol as self-medication produce presentations where treatment of the anxiety unlocks the drinking.
Other substance use disorders are frequently co-occurring and change treatment considerations.
Cognitive impairment in older adults may be produced by alcohol, may worsen alcohol use, or may reflect independent dementia. Distinguishing these matters because the alcohol contribution is partially reversible.
Personality disorders (particularly borderline, antisocial) frequently co-occur and change engagement dynamics.
Common co-occurring conditions
Comorbidity is the rule rather than the exception.
- Major depressive disorder: about 20 to 30 percent of people with AUD meet criteria for MDD in a given year, and about 40 to 50 percent do across the lifespan
- Anxiety disorders (particularly social anxiety, GAD, panic): about 30 to 40 percent
- PTSD: elevated compared with the general population, particularly in combat veterans and survivors of interpersonal violence
- Bipolar disorder: elevated compared with the general population, and AUD complicates bipolar course
- Other substance use disorders: common, particularly cannabis, nicotine, opioids
- Sleep disorders
- Personality disorders, particularly borderline and antisocial
- Attention deficit hyperactivity disorder: elevated, and AUD can develop as untreated ADHD leads to self-medication
Many people with alcohol use disorder are self-medicating an underlying condition, and treating that condition is essential to sustained recovery. Sequential treatment (alcohol first, then the other condition) is often less effective than integrated treatment.
Medical consequences include liver disease (fatty liver → alcoholic hepatitis → cirrhosis → hepatocellular carcinoma), cardiovascular disease, hypertension, atrial fibrillation, several cancers, cognitive impairment, peripheral neuropathy, pancreatitis, gastritis, esophageal varices, and increased mortality across many categories.
Treatment
Treatment works. The mistaken belief that alcohol use disorder rarely responds to treatment is not consistent with the evidence. Real recovery, including in severe cases, is common. The specific challenge is engaging people in treatment; once engaged, outcomes are substantial.
### Medications with strong evidence
Three FDA-approved medications plus two off-label options with growing evidence.
Naltrexone. Opioid receptor antagonist. Reduces craving and heavy drinking days. Available as an oral daily medication (50 mg) or a monthly injectable (Vivitrol, 380 mg IM). First-line for most patients not taking opioid medications for pain. Meta-analyses show naltrexone reduces relapse to heavy drinking by about 17 percent and reduces heavy drinking days. Well tolerated for most patients; nausea is the most common side effect. Requires no active drinking at start (not a full detox requirement, but ideally 3-7 days of no heavy use). Cannot be used with opioids. Extended-release injectable helps adherence for patients who struggle with daily medication.
Acamprosate. GABA and glutamate modulator. Reduces relapse in people already abstinent. Three times daily dosing (666 mg TID). Well tolerated. Requires normal renal function; contraindicated in severe kidney disease. Meta-analyses show reduction in return to any drinking. Best for patients who have achieved initial abstinence and want to maintain it.
Disulfiram (Antabuse). Aldehyde dehydrogenase inhibitor. Produces an unpleasant reaction (flushing, nausea, tachycardia, headache) when alcohol is consumed. Effective for people committed to abstinence and who take it consistently, particularly with supervised administration. Historical mainstay, less used now than naltrexone or acamprosate but still valuable for specific patients. Requires patient understanding of the reaction and no medical contraindications (severe cardiac disease, psychosis).
Topiramate. Off-label. Growing evidence base including several RCTs. Reduces heavy drinking days and craving. Titrated slowly to reduce side effects (cognitive slowing, paresthesias, weight loss). Reasonable second-line or first-line option in patients with certain profiles.
Gabapentin. Off-label. Evidence base growing, particularly for reducing craving, sleep disruption, and anxiety in alcohol withdrawal and early recovery. Well tolerated for most patients. Some risk of misuse in patients with polysubstance use.
Other options with less evidence but occasional use: baclofen, ondansetron (particularly for early-onset alcoholism), nalmefene (approved in Europe).
### Psychosocial treatments with evidence
Cognitive behavioral therapy for substance use (CBT). Structured therapy targeting the thoughts and situations that maintain drinking, teaching coping skills, relapse prevention. Manualized versions available; typical course 12 to 20 sessions.
Motivational interviewing / motivational enhancement therapy. Brief interventions using specific communication techniques to strengthen the person's own motivation for change. Effective as standalone treatment for mild AUD and as an engagement tool for more severe cases.
Contingency management. Structured reinforcement (vouchers, prizes) for verified abstinence. Strong evidence in stimulant and opioid use disorders; growing evidence in AUD.
12-step facilitation therapy. Structured therapy that supports engagement with Alcoholics Anonymous. Kelly et al. (2020) Cochrane review found 12-step facilitation comparable to or better than other treatments for maintaining abstinence in some outcomes.
Mutual-help groups. AA is the largest and most-studied. SMART Recovery, Refuge Recovery, Women for Sobriety, and others offer alternative frameworks. Meta-analyses show meaningful benefit for many patients, with the effect strongest for people who attend regularly and engage with the community. AA isn't the only path and isn't a fit for everyone; it also isn't nothing.
The combination of medication and psychosocial support typically outperforms either alone.
### Levels of care
Care is matched to severity using American Society of Addiction Medicine (ASAM) criteria:
- Level 1: Outpatient services (weekly or less frequent), appropriate for mild AUD with stable home environment
- Level 2: Intensive outpatient programs (IOP, 9-19 hours/week), for moderate AUD or when outpatient alone isn't enough
- Level 2.5: Partial hospitalization programs (20+ hours/week), daytime intensive treatment while living at home
- Level 3: Residential treatment (24/7 supervised), for severe AUD or when home environment isn't stable
- Level 4: Medically managed inpatient, for severe withdrawal management or acute medical/psychiatric issues
The level is chosen by clinical severity, medical needs, home environment, and history of past treatment. Higher intensity isn't always better; matching to actual need is what improves outcomes.
Abstinence versus reduced drinking
Traditionally, abstinence has been the primary treatment goal. Current evidence supports that reduced-drinking goals are viable for many patients, particularly those with less severe alcohol use disorder, and that setting an initial goal of reduction can be a bridge to abstinence for some or a stable outcome for others.
For patients with severe alcohol use disorder, significant liver disease, prior severe withdrawal (particularly withdrawal seizures or delirium tremens), or during pregnancy, abstinence is usually the safer goal.
The choice is individualized and often revisited during treatment. Setting the goal collaboratively rather than imposing it often improves engagement.
Epidemiology
Lifetime prevalence of AUD in the United States is about 29 percent by NESARC-III methodology (Grant et al. 2015), with 12-month prevalence around 14 percent. This makes AUD one of the most common psychiatric conditions.
Prevalence varies substantially by age (highest in young adults 18-29 years old, declining with age), sex (higher in men, though the gap is narrowing), and race/ethnicity.
Alcohol-related mortality has increased in the United States over the last two decades. The Centers for Disease Control estimated about 178,000 excess deaths per year attributable to alcohol in 2020-2021, up substantially from prior decades.
International prevalence varies substantially by region. WHO Global Status Reports on Alcohol and Health track cross-country patterns.
Course and prognosis
The course of AUD varies. Some patients have episodic patterns with periods of remission. Others have chronic progressive courses. Some have late-onset AUD in older adulthood. Recovery is real and common: population studies suggest a substantial proportion of people who ever met criteria for AUD are in sustained remission at any given time, and many achieved this without formal treatment.
Predictors of better outcomes include: engagement in medication-based treatment, stable housing, employment, supportive relationships, absence of severe co-occurring disorders, and later age of onset. Predictors of worse outcomes include: severe co-occurring depression or bipolar disorder, PTSD, other substance use disorders, early age of onset, and unstable housing.
Return to drinking is common in early recovery and is not evidence that treatment failed. The pattern is usually one of decreasing frequency and severity of relapses over time. Continuous abstinence isn't required for meaningful improvement in quality of life and function.
Cultural considerations
Drinking patterns and their meaning vary substantially by culture, and treatment approaches need to reflect the person's context. Some considerations:
- Cultural contexts where drinking is central to social life produce different treatment challenges than contexts where drinking is stigmatized
- Religious identity (particularly traditions that prohibit alcohol) affects both risk and recovery
- Cultural attitudes toward professional mental health treatment vary
- Immigration status, discrimination experience, and minority stress may contribute to drinking patterns and affect treatment engagement
- Mutual-help groups (AA and alternatives) have different cultural profiles in different communities
- Family involvement in treatment is normative in some cultural contexts and inappropriate in others
Living with AUD
For the person. The single most useful thing to know is that shame is a symptom of the condition, not a fair verdict on you. Telling one clinician the truth about what's happening is often the biggest step in the entire treatment. Nothing else can start until that one step happens.
Some things that help:
- Getting a medical evaluation to assess withdrawal risk before stopping
- Considering medication as a first-line option, not just something to try after therapy fails
- Building a treatment team that includes at least one clinician and often a therapist and a mutual-help community
- Removing alcohol from the home during early recovery when possible
- Notifying trusted people about the recovery attempt so they don't offer drinks
- Planning for high-risk situations (work events, holidays, celebrations)
- Sleep, nutrition, and structured activity as protective factors
- Treating co-occurring depression, anxiety, PTSD, sleep problems
For family. Some things that help:
- Learning about AUD as a medical condition
- Al-Anon or similar family support groups
- Being clear about what you can and can't sustain
- Not covering for the person's drinking-related consequences (protecting from natural consequences often maintains the pattern)
- Being consistent and non-judgmental in what you communicate
- Safety planning if there is violence
- Care for your own mental and physical health
Sources
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Section on Substance-Related and Addictive Disorders. American Psychiatric Publishing, 2022.
- World Health Organization. International Classification of Diseases 11th Revision (ICD-11). Chapter 6, Disorders due to substance use. 2022.
- Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013. JAMA Psychiatry. 2017;74(9):911-923.
- Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder. American Journal of Psychiatry. 2018;175(1):86-90.
- US Department of Veterans Affairs and US Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders. 2021.
- Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews. 2020;3:CD012880.
- Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311(18):1889-1900.
- Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study. JAMA. 2006;295(17):2003-2017.
- Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews. 2010;12:CD001867.
- Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews. 2010;9:CD004332.
- Blodgett JC, Del Re AC, Maisel NC, Finney JW. A meta-analysis of topiramate's effects for individuals with alcohol use disorders. Alcoholism: Clinical and Experimental Research. 2014;38(6):1481-1488.
- Anton RF, Latham P, Voronin K, et al. Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial. JAMA Internal Medicine. 2020;180(5):728-736.
- Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT). Addiction. 1993;88(6):791-804.
- Centers for Disease Control and Prevention. Alcohol Use and Your Health. Reviewed 2024.
- National Institute on Alcohol Abuse and Alcoholism (NIAAA). Rethinking Drinking and treatment resources. 2024.
- World Health Organization. Global Status Report on Alcohol and Health 2018.
Read how Shrinkopedia builds and reviews its content.
How to cite this page
- Short
Alcohol use disorder. Shrinkopedia, medically reviewed by Shariq Refai, MD, MBA. https://shrinkopedia.com/conditions/alcohol-use-disorder/- APA
Shrinkopedia. (2026, July 13). Alcohol use disorder. Medically reviewed by Shariq Refai, MD, MBA. https://shrinkopedia.com/conditions/alcohol-use-disorder/- MLA
"Alcohol use disorder." Shrinkopedia, 13 July 2026, https://shrinkopedia.com/conditions/alcohol-use-disorder/.
Click a citation to select it.
See where this fits in the Atlas: how your mind works →
When evaluation may help
Reading a reference is not the same thing as being evaluated. If what you just read matches your own experience closely, if the pattern has been getting in the way of work, relationships, or daily life, or if you have questions that only a clinician who knows your situation can answer, a professional evaluation is a reasonable next step. Reading forward without seeking evaluation is also a reasonable choice for many people. There isn't one right answer.
A few honest options, presented in no particular order:
Walk the connection from this entry outward.
- 1 CONDITION Alcohol use disorder (current)
The Knowledge Path is a curated walk. Every step is one decision away from the next.
You are here: Shrinkopedia, the concept layer of The Shrink Network.
Understand the idea here first, then follow it to the property that takes it further.
Read a related condition →Want to understand more first?
- Understand anxiety at AnxietyResource →
- Work with the pattern at shrinQ →
- Consider clinical evaluation at shrinkMD →
Disclosure: shrinkMD is the clinical care practice within The Shrink Network, the same network that publishes Shrinkopedia. Shrinkopedia takes no referral or affiliate commission for care.